74 related articles for article (PubMed ID: 265067)
21. Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia.
Stryckmans P; Debusscher L; Socquet M
Cancer Res; 1976 Sep; 36(9 pt.1):3034-8. PubMed ID: 1067897
[TBL] [Abstract][Full Text] [Related]
22. Monitoring trace elements in cells from the blood of patients with acute myeloblastic, chronic lymphocytic and chronic granulocytic leukemia.
Aleksandrowicz J; Dobrowolski JW; Balechala P; Lisiewicz J
Haematologica; 1982 Jun; 67(3):437-41. PubMed ID: 6815003
[No Abstract] [Full Text] [Related]
23. Ultrastructural features of basophil and mast cell granulopoiesis in blastic phase Philadelphia chromosome-positive leukemia.
Parkin JL; McKenna RW; Brunning RD
J Natl Cancer Inst; 1980 Sep; 65(3):535-46. PubMed ID: 6931933
[TBL] [Abstract][Full Text] [Related]
24. [Glycosaminoglycans in leukocytes in myeloproliferative disorders].
Kharchenko MF; Shatskaia TL; Ostroumova SS; Rybakova LP; Shcherbakova EG
Vopr Med Khim; 1984; 30(4):86-91. PubMed ID: 6594825
[TBL] [Abstract][Full Text] [Related]
25. [Granulocyte chalone normally and in acute myeloblastic and chronic myeloid leukemias].
Bala IuM; Kovalevskaia NP
Probl Gematol Pereliv Krovi; 1981 Nov; 26(11):14-8. PubMed ID: 6459577
[No Abstract] [Full Text] [Related]
26. [Blood fibrinolytic activity in patients with acute leukemia and blast crisis of chronic myeloleukemia].
Naumova GA; Andreenko GV; Orlova LD
Probl Gematol Pereliv Krovi; 1970 Oct; 15(10):3-11. PubMed ID: 5285585
[No Abstract] [Full Text] [Related]
27. [Changes in the erythrocyte, 2,3-DPG and ATP content in leukemic diseases].
Iordanova E; Arnaudov G
Vutr Boles; 1981; 20(2):119-23. PubMed ID: 6942591
[TBL] [Abstract][Full Text] [Related]
28. [Cytochemical study of lactic acid in leukemia cells].
Piette M; Durand G
Nouv Rev Fr Hematol; 1969; 9(5):688-96. PubMed ID: 4313092
[No Abstract] [Full Text] [Related]
29. [Leukocyte glycosaminoglycans in various forms of myelo- and lymphoproliferative blood diseases].
Kharchenko MF; Shatskaia TL; Shcherbakova EG; Abdulkadyrov KM
Vopr Onkol; 1986; 32(10):47-53. PubMed ID: 3465089
[TBL] [Abstract][Full Text] [Related]
30. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
Andreasen RB; Olsson L
J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
[TBL] [Abstract][Full Text] [Related]
31. [Amino acids and vitamin B 12 in myeloid leukemia].
Desser H; Höcker P; Weiser M; Schuh H; Pittermann E; Stacher A
MMW Munch Med Wochenschr; 1976 Nov; 118(46):1497-8. PubMed ID: 825770
[No Abstract] [Full Text] [Related]
32. The nature of leukaemia: neoplasm or disorder of haemopoietic regulation?
Metcalf D
Med J Aust; 1971 Oct; 2(15):739-46. PubMed ID: 5286826
[No Abstract] [Full Text] [Related]
33. [Megakaryocytes in the bone marrow smears from patients with various types of leukemia accompanied by thrombopenia].
Kemona H; Prokopowicz J
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1982; 26():183-9. PubMed ID: 6190213
[No Abstract] [Full Text] [Related]
34. Expression of MLR-S in human myeloid, monocytic and erythroid cell differentiation.
Han T; Minowada J
J Clin Lab Immunol; 1980 Nov; 4(3):169-73. PubMed ID: 6451711
[TBL] [Abstract][Full Text] [Related]
35. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
36. [Blood coagulation changes in children with acute myelogenous leukemia: thrombin effect or proteolysis].
von Kries R; Ebell W; Jürgens H; Göbel U
Klin Padiatr; 1984; 196(3):174-7. PubMed ID: 6590923
[TBL] [Abstract][Full Text] [Related]
37. [Changes in the proteinogram and serum immunoglobulins in acute and chronic myeloleukosis].
Sarnitskiĭ IP; Tishchenko LM; Guseva SA; Minchenko ZhN
Vrach Delo; 1984 Jan; (1):90-3. PubMed ID: 6583885
[No Abstract] [Full Text] [Related]
38. Imbalance in the nucleotide pools of myeloid leukemia cells and HL-60 cells: correlation with cell-cycle phase, proliferation, differentiation, and transformation.
de Korte D; Haverkort WA; de Boer M; van Gennip AH; Roos D
Cancer Res; 1987 Apr; 47(7):1841-7. PubMed ID: 3469022
[TBL] [Abstract][Full Text] [Related]
39. Phagocytic and bactericidal capacities in neutrophils from patients with acute and chronic myelocytic leukemia.
Sasada M; Nishiyama H; Sawada H; Nakamura T; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):709-18. PubMed ID: 281081
[No Abstract] [Full Text] [Related]
40. Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation.
Foa R; Guarini A; Gillio Tos A; Cardona S; Fierro MT; Meloni G; Tosti S; Mandelli F; Gavosto F
Cancer Res; 1991 Feb; 51(3):964-8. PubMed ID: 1988139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
